Document rLj9gpVVRa5BQBqXLmEoz1oq
--_--
0
.
0 TRHesEearRchICoMrpMorUatiNonE
AR226- 1906
|
|
0 son 3M Corporate Toxicology
|
Cc
Building 220-26-02, 3M Center
|
St. Paul, MN 55144-1000
C
C
FINAL REPORT
0
SuisTle
Cell Proliferation Study with N-Ethyl Perfluorooctanesulfonamido Ethanol (N-EtFOSE;
|
o
3M T-6316.11), Perfluorooctane Sulfonic Acid Potassium Salt (PFOS; 3M T-6295.16), and
i
NN-Ethyl Perfluoroctanesulfonamide (PFOSA 3M T-7091.1) in Rats
i
C
Teg Ailes
i|
C N-EtFOSE
C
PFOS
PFOSA
C
Authors:
C
Gary W. Wolfe, Ph.D., D.A.B.T.
Kimberly A. Layton, B.S.
C
SCtoympletiDoaen:
C
May 2, 2000
|
Performing Laborsiory:
|
c
`Therlmmune Research Corporation
|
C
15 Firstfield Road
|
Gaithersburg, MD 20878
C
TRCStudyNumber:
C
1132-100
Cc
CONTAIN NO Cp!
|
C
|
3/5
|||
N-E{FOSE, PFOS, PFOSA
TRC No. 1132-100
|
C
TABLEOFCONTENTS
|
C COMPLINCESTATEME+N1T1 sesso seeseseessesiasiseeneend
|
C
STUDY IDENTIFICATION .......esuuesensenannnnnnnannnenns "
reir
STUDY PERSONNEL
++i
6
0 INTROD+U++C+eTtIe ON eeseee eases
|
TESTANDCONTROLARTICLES +++. sesasessniae snen snD
|
c TESTANIANMDHAUSBLANDSRY
+. ooeeeaessnness cnn10
O
MEGTuHnO,DASgene tSHs DRe E1L1At 1V+ISv viverensrmserererernes `TestArticle Formulation3nd AGRIGSEOn +++.++. 210 eeroeesines
1111
Cc
ClinicalCheriseaadCompoundLevelAnsys + -.....-.10.o 1.o -11.3
o1
CP OolTl PRarGoiBfmeImoGnriwiaTrdeanisa eTCssoayelmiCeon- lslseonceidsC onI1m0do mAulnA ycesnhtsiers= porcaEvhhalneu~ ramteiieonec+aae. 1lr.ee.r.e. rrer1u.. n.r.s 1B16
|
0
TRiseCmolLlieirnnToRrgSEico+nMi-cros-copi+c Evaehoaetieorne ooo~~~... 11S6
Hiapabelogy e+1. LL
C:
FoodoydCWoeingmhmsapntdoBon1dy +Weig+h-tG-an+s+111... 1.0.11
ie e
!
C
ClTioniMcaaltOUaElTCBOORUSR +-+-+++1+111+ ve esrmsesrmesrrsinsinirniinisiis 16 TerminalBody WeighsadLives Weighs |. -.-...1...1 1111
||
o SIGNATURBPAGE ++nesi sss
19
|
C 1 SUMMARY OFBODYWEIGHTS (Gams)... .vosvesvsesssssnn2n0s
C IA - SUMMARYOFBODYWEIGHTGAINS Gram) ..........o..oooroooers 2
|
2 - SUMMARY OFFEEDCONSUMPT(IGROINN) ........o.oo oovesssnnn 8
i
C 5 = SUOM FCLIM NICAA LOBSER RVATY IONS ............o.oovoirirsnn25
C 3MCorporateToxicology
2
|
3/6
|
t
N-EtFOSE, PFOS, PFOSA
"TRC No. 1132-100
i
OT asso nso eros | C
`TABLE OF CONTENTS (contd.)
i
`TABLES(Continued)
C aA
om
i
C
1 - MALES:INDIVIDUALBODY WEIGHTS (Grams) +. ++. +e ev vvvvnannnnns 32
|
Im.
INDBI ODYV WEII GHD TGAIU NS(A GramL s) +. + ove vnneennaaneenes. 35
1
C
2
.
INDFI EEV DCOI NSUD MPTU IONA (GraL ms) ......vvvvnnnnnuuuanneenn3.7
oO
3 = INDIVIOBSEDRVAUTIONASL+.C..LveeIvreNervI erseCnseAsenL .40
5 4 INDIVIDUALTESTMATERIAL CONSUMPTIGpOaN) oe... 55
0 5. IWNEDGIVHITDRUAATLIAOBSSOLcUooTrELIVERWEIGHTS(Gams) ANI D ORGANTO Bs ODY
|
c
||
o
|
C
||
Cc
|
C
:C
||
C
C
C
rrr
||
C
7
C N-EFOSE, PFOS, PFOSA
TRC No. 1132-100
COMPLIANCE STATEMENT
C
Cell Proliferation Study with N-ECFOSE, PFOS, and PFOSA in Rats
C
`This study was conducted in the spiritofthe Good Laboratory Practice Regulations as
|
o set forth in Title 21ofthe U.S. Code of Federal Regulations Part 58, issued December 22,
1978 (effective June 20, 1979) and was not reviewed by Quality Assurance. There vere no
|
o deviation from the aforementioned regulations which affected the quality or integrityofthe
|
c
studyorthe interpretationof theresultsinthereport.
1
0
i
C Study Director:
C
C
Wl: shoo
|
Cc
Gary {. Wolfe, Ph.D. /D.A.B.T./Date:
|
o
|
C
||
c
: 3M Corporate Toxicology
3
-
3/8
`
|
o N-EtFOSE, PFOS, PFOSA
TRC No. 1132:100
i
STUDY IDENTIFICATION
O
Cell Proliferation Study with N-E(FOSE, PFOS,andPFOSA in Rats
C TRC Study Number:
1132-100
|
0 Test Articles:
N-Ethyl Perfluorooctanesulfonamido Ethanol (N-ECFOSE) | PNe-rEftlhuyolroPoecrtfalnueorSoucltfaonneiscuAlcfoindaPmiodteas(sPiuFmOSSaAl)t (PFOS) i
a
`Sponsor:
0
3M Corporate Toxicology
|
Building 220-2E-02, 3M Center
|
St. Paul, MN 55144-1000
|
c Sponsor's Representative:
M3aMrvCionrpTo.raCtaeseT,oxDi.cVo.lMo.gy, Ph.D.
St. Paul, MN 55144-1000
}
C
PFahxo:ne6:5615-713-37-3137-753180
In
Study Director:
o
C
TGahreyrlWm.muWnoelfRee,sePahr.cDh.,CoDr.pAo.rBat.iTo.n
G1a5itFihresrtsfbiuelrdg,RoMaDd 20878
}i
Phone: 301-330-3723
|
C Study Monitor/Principal Investigator: SPaatnhdorlaoRg.y EAlsdsroicdigaet,esPIhn.tDe.rnational Phone: 301-663-2036.
C Study Timetable Study Initiation:
January 12, 1999
|
C
I4n8i-tiHaotuiornPoofsDtoDsoisneg:Sacrifice:
FFeebbrruuaarryy 2235,, 11999999
7-Day Post-Dose Sacrifice:
C
14-DayPostDose Sacrifice:
March 2, 1999 March 9, 1999
i
1:Week Recovery,
C
4-Wesk Recovery
AMparriclh6,161,9919999
C
Study Termination:
April 6, 1999
||
3M Corporate Toxicology
5
|
t
|
3/9
C ||
Cc N-E(FOSE, PROS, PFOSA
TRC No. 1132-100
i
| Cc
Cell
Proliferation
STUDY PERSONNEL Study with N-EtFOSE, PFOS,
and
PFOSAinRats
| |
C
|
Study Director:
Gary W. Wolfe, Ph.D., D.A.B.T.
|
o
|
Study Pathologist:
Carolyn Moyer, D.VM., A.C.V.P.
|
o Veterinarian:
Edvard T. Greenstein, D.V.M., A.CLAM.
|
C Quality Assurance Director:
E. Paige Lacy, B.S.
1|
Cc
HFaecailltihtyaMnadnSaagfeetry Officer/
Robert K. Blackford, A.A., LATG
!|
o Technical Supervisor:
Patrick Benson, B.S., LATG
|
o Report Supervisor:
Lori B. Kaiser, B.S.
|
Cc Technical Writer/Project Leader:
Kimberly A. Layton, B.S.
|
0 | o Laboratory Head Technician:
C Technicians:
C C
Paula Davis, B.S. Sharron Stewart
DKealnliyelMAu.ssJealcmkan, B.S.
BFreeltetciCahBainsehyo,p,B.SA.,.A.LALTAGTG
Francis Larissa
NOenhwruebeemceknyie,
B.S.
JPaouAlnnMaMrtuirnp,hBy.S.
c | C E 3M Corporate Te oxicology r5ste |
r-- ee------------------el-- ---- ---------- ---- ------
320
|
C
C N-BFOSE, PROS, PFOSA
G
SUMMARY
|
TRC No. 1132-100
|
|
C
`This study was designed to assess cel proliferation and peroxisome proliferation in rats
|
administered N-Ethy1 Prfluorooctanesulfonamido, Perfluorooctane Sulforic Acid PotassiumSalt,
|
O N-Ethyl Perfluoroctanesulfonamide and Wy-14,643 i the diet. Animals in Groups 1, 2, and 3
|
received the test articles in the feed for 48 hours, 7 days, and 14 days, respectively, and were
|
C necropsied immediately following completion of exposure. Animals in Groups 4 and received
o the test articles in the feed for 14 days followed by a 1-week and 4- week recovery period,
respectively, andwere necropsied following th recovery period. All Groups were divided into
|
O Subgroups. Subgroups 1, 2, 3,4, 5, 6, and 7 received 0, 300, 100, and30ppm of N-E(FOSE,
|
20 ppm of PFOS, 100 ppm of PFOSA, and 100 ppm Wy 14,643 respectively. In Group 1, each
|
GC
`Subgroupcontained 10animalswiththeexceptionofSubgroup 7withonly $animals. In Groups
|
0 2,3, 4, and 5, Subgroup 1 contained 10 animals and received the control diet. The remaining
|
`Subgroups contained animals each.Criteriaevaluated for test article effect included mean body
|
C weights and body weight gains, feed ndtestmaterial consumption, clinical observations, clinical
|
pathology, organ weights, gross pathology, histopathology, cell proliferation,
C immunobistochemistry, palmitoyl-CoA oxidase activity, and electron microscopy.
{
o
`Therewerenotreatmreelantetfindingsforfeed consumption,testmateialconsumption,
|
and clinical bservations. However, there weretreatment.related effects found in the mean body
Cc
`weightsandmeanbodyweightgainsoftherecovery animals.Therewere decrseeeanisnmeeasn
!
" bodyweiongSthudytDasy (SD) 15forthe 1-week recoveryanimalsinthe300 ppm N-EXFOSE,
|
C
PFOSA, and Wy-14,643 groups. In addition, there were decreases seen in mean body weight
|
C gaoniSDn8-s15forthe1-weekrecoveryanimalsinthe 300and 100ppm N-EGFOSE, PFOSA,
|
and Wy-14,643 groups and for the 4-week recovery animals on SD 8-15 in the 300 ppm N-
C
EXFOSE group and on SD 22-29 in the 30 ppm N-EFOSE group.
Treatment relate findings were also see in absolute andrelative(g liver weight body
C weight) ivr weights. Increases were seen inthe absolut ver weights of the 48-hour post dose
|
C sacrifice animals inthe 100 ppm N-ECFOSE and 100ppm Wy-14, 643 graondauninpcreasse in
!
o 3M Corporate Toxicology
7
i
C
;
ee rr ee------------------------
32/
C
NI
PFOS, PFOSA
TRC No. 1132-100
!
C
the relative liver weight in the 100 ppm Wy-14,643 group. For the 7-day post-dose sacrifice
|
!
`animals, absoluteliverweightswereincreasedin the 100ppm PFOSAand 100ppm Wy-14,643
o groupsand relativeorganweightswereincreasedinthe 300ppm N-E(FOSE, 100 ppm PFOSA,
|
and 100 ppm Wy-14,643 groups. Absolute and relative liver weightsofthe 14-Day post-dose
|
C sacrificeanimalswereincreased ithe300ppm N-E(FOSE relativeonly), 100ppm PFOSaAn,d
C
100 ppm Wy-14,643 groups. Terminal body weights of the one week recovery animals were
decreased in the 300 ppm N-E(FOSE, 100 ppm PFOSA, and 100 ppm Wy-14,643 groups.
|
co
Absoluteliverweightswereincreasedinthe300ppm N-EtFOSEgroupoftheseanimals. Also,
|
relativeliver weightswereincreasedinthe300 ppm N-E(FOSE,100ppm PFOSA, and100ppm
i
CO
Wy-14,643 groups. In addition, absolute and relative liver weightsofthe four week recovery
|
0
animalswereincreasedinthe 300ppm N-E(FOSE and100ppmPFOSA(relativeonly)groups.
|
Results of clinical pathology, histopathology, cell proliferation, immunohistochemistry,
|
I]
palmitoyl-CoA oxidase activity, and electron microscopy will be reporied separately.
i
:0
||
c
C
||
Cc
|
Cc
3M Corporate Toxicology
8
|
|
Cc
||
o
|
Cc
N-EFOSE,PF~ O~ S,PTF RCNO o.1S 132A -100
o
INTRODUCTION
GC
`This study was designfeod assess cell proliferation and peroxisome proliferation in rats
|
administered N-E(FOSE, PFOS, PFOSA and Wy-14,643. The design of this study included
o
groups of animals. Each Group contained 7 Subgroups. Subgroups 1, 2, 3, 4, 5, 6, and 7
|
received the following: Control (0 ppm), N-E(FOSE (300 ppm, 100 ppm, 30 ppm), PFOS (20
C ppm), PFOSA (100 ppm) and Wy-14,643 (1000 ppm), respectively. Dosing was initiated on
o February 23, 1999 for all groups. Groups 1, 2, and 3 each received thetest diets for 48 hours,
|
7 days, and 14 days, respectively and interim necropsies occurred on February 25, March 1, and
|
C March 8, 1999, respectively. Groups 4 and 5 received the same test diets for 14 days and
|
terminal necropsies occurred afer a 1 and d-week recovery period on March 16 and April 6,
Em | 0
1999, respectively.InGroup 1, thetestdietswere administerteod 10 animals/Subgroupwith the
|
Cc excoefSupbgtrouip7owitnh5 animals. In Groups 2, 3,4, and 5,th testdiets were administered
|
105 animals/Subgroup, with the exception of Subgroup 1 with 10 animals which received the
0
TEST AND CONTROL ARTICLES
i
t
One 34.88 gsamploef N-E(FOSE T-6316 (Lot No. 30035, 30037,and30039 combined),
|
0 a waxy solid, was received from Covance Laboratories, Inc., Madison, WI, on December 31,
|
0 1998andstoredatambienttemperature. Thepurity was 98.1%andwassableforgreaterthan
|
5 years. One 81.97 g sample of FxI2 Fuorad T-7091 (PFOSA) (Lot No. not provided), an
|
C amber waxy solid, and one 97.13 g sample of FC-95 Fluorad T6295 (PFOS) (Lot No. Not
|
provided), a white powder, were received from 3M, St. Paul, MN, onDecember 31, 1998 and
C storedatambienttemperature.Bothtestartihacdalpueritsy assumtoebde 100 %andwereboth C stable for greater than 5 years. A 1 gram sample of Wy-14,643 (Lot No. 119904), a white
powder, was reseived fromCaymanChemical, Ann Arbor, MI,on February 22, 1999and stored
Cc at ambient temperature. The purity was greaterthan 98% and was stable for at least two years.
C 3M Corporate Toxicology
9
|
C
|
| C
Cc N-EFOSE,PROS, PFOSA
TRCNo. 132100
|
)
Areservesample ofeachlot wastakenand storedatambienttemperature.Thesesamples
o were transfered to the Sponsor after the completion of the n-lfe phase. Any remaining test
[
C
`material will be returned to the Sponsor' representative.
{
0
TEST ANIMALS AND HUSBANDRY
Rats were used because of the extensive historical data base, and FDA requirements for
0 a rodent species. Two hundred forty-cight male approximately five weeks old Crl:CD9(SD) IGS
C BR ras were received from Charles River Laboratories, Raleigh, North Carolina on February 9,
|
1999. The animals were assigned temporary animal numbers upon receipt. The rats were
|
Oo
acclimatedtolaboratory conditions for thirteen days prior o initoifatrteaitmoennt.Eachrat was
0 identifiedbyaneartagandcagecardbearing auniqueanimalmumber.
:
Animalswerehousedoneper cage fromrectoeteriminpatiton. Dutrheistundy,gall
C animalswerehoused instainlesssielsuspendedwirecages onstainless-steel racksequippedwith
i
plastic backed polyliners. Animals were provided with fitered tap water ad libitum via an
C Edstrom automatic watering system or water bot. TekladTM 7012 Certified Rodent diet was
. available ad libitum in glas jars with stainless steel lids and followers. Fresh food was provided
C weekly. The water is analyzed at east two times per year for contaminants and specific microbes.
o The feed s analyzed by the manufacturer for concentrationsofspecified heavy metals, aflatoxin,
i
chlorinated hydrocarbons, organophosphate, and specified nutrients. The results otfh feed and
i
a water analyses are on fileat Therlmmune Research Corporation. No contaminants were known
|
0 10 be present inthediet or water at levels which might interfere with achieving the objectives of
|
:
the study.
C
During the study period, the temperature and relative humidity of the study room were
recorded twice daly. In addition,theanimalroomtemperature and humidity were continuously
Cc monitored by a ReesTM Scientific Monitoring System. ~The animal room was set to maintain
temperatures at 64 and 79Fand relative humiditybetween30%and 70%. A 12-hour light12-
C hour dark cycle was maintained through the acclimation and study periods.
C
|
oC
3M Corporate Toxicology
10
|
0
|
3IRY
|
C N-EtFOSE, POS, PFOSA
TRC No. 1132-100
|
METHODS
| i
UT] po L
GArousp signandmDoeseLnevetls
|
Following examination by astaffveterinarian for physical condition, the rats were assigned to the study:
|
GrroiumpeNPuomibne)r|| Co[ ntrol[og eT~m10r0oppsms| 50
| |
pros | op|
PROSA | cooppm)|
Wyld| 00 pom)
TomiNo. | of Animals
|
Olde [oo[ofo m]>m [] 1
IPE CNIE ENHE CECN Cc
Da
be oo[oT Te] 0 (14 Days)
te |"1 [oo [> Le] 0 frome
[mim|" | 2| | [=[7[> [=] 4 wk recover
5
| |
c c HEH HE EC a | 0
Computer-generated random numbers were used for assignment to groups. At the time
a: owfeirgahntd,oamnidzatthieonm,eathnebwoedigyhwteviagrhiiastiofonoreftahchegarnoiumpaalsndusseedxdwiedrneontoexscteateidst+ic2allSy.dDi.foffetrhenet.meTahne |
body weights at initiation of treatment ranged from 175.2 g 10 271.1 g. Extra animals were
C
removed and discarded without necropsy.
C followiDnigeptraorcyedfuorrem:ulations ofth test articles and Teklad 7012C Feed were prepared using the ||
o
For Group 1, the appropriate amount of feed was weighed into a plastic container and
i
C
stored at ambient temperature and protected from light, For each dose level, the appropriate
|
0 e-- 3S MeC-- rorp--or--a--te---- To--xic-- --oloEgEy--------I--n ------------eee
||
C
||
--
328
|
C ||
0
N-EtFOSE, PFOS, PFOSA-
TRC No. 1132-100
1
C
QuantityofTeklad7012Cfeedwasaccurately weighed ntoplasticcontainers. Theproperamount
oC apopfrotpheritaetsteaamrtoiuclnet owfaascewteoingehweda,s audsdiengd 0aasltoaiwntlheesstesstteemlatsepraitaulla0, gi0ntionao gslolaustsiobne.akeAr.dietTahrey
| i
C
premix was prepared for each dose level of each test article by adding the appropriate amount of
feed with the test article with a sinless steel spatula until no feed/chemical agglomerates
|
|
.
remained. Additional feed was added in increments that approximately doubled the amount of
C
c
`premix until an adequate premix was achieved. Following each addition, the formulation was
`mixedthroughlywithastainlesssteelspatula.When thetestarticle/feedmix wastransferredfrom
|
|
`onecontainertoother,thecontainerwasrinsed atleastthreetimeswithpremixfeed. Allfeed
|
C
used for rinsing and preparing the premix was taken from the preweighed feed in the plastic
|
o
containers for each dose level.
|
From the preweighed feed, 10 kilograms was layered evenly into the Paterson-Kelly
o
Blender. The premix wasthenpoured in equal amounts into therightand left blender ports and
|
spread evenly. The premix container was then rinsed three times with the vehicle, from the
|
C
preweighed feed. Bach rinse was poured evenly intothe blender. Theremainingpreweighedfeed
|
0
was evenly poured into the blender. The blender was sealed and the dietary formulation was
blended for approximately 30 mites.
C
Dietary formulationswerestoredin sealed plastic containersandwerestable for 21 days
|
at room temperature. The formulations were dispensed into glass jars with stainless steel
i
O followers and lids. Diets were prepared for the entire study in one Mix.
C
Two 100 g samples of each batch (per mix) of each dose level of the test article
|
|
formulation and stored were stored in heat sealable foil bags protected from light at room
C
temperature. At the requestofthe Sponsor,sampleswil be retumed for analysis. Unless used
| |
0
for analysis, sampleswillbediscaratdleeasdtonemonthafterthecompletionof the in-life phase.
|
4
`Observations andRecords
L
Each animal was observed twice daily (a.m. and p.m.) for mortality and moribundity.
!
|
Cc
Findings were recorded as they were observed.
|
o
3M Corporate Toxicology
12
| O _-- 00]| 324
|
C
|
C
N-EFOSE, PFOS, PFOSA
TRC No. 1132-100
!
Individual body weights and physical examinations were recorded prior to treatment (at
!
C
randomization (physical examinations not reported) and weekly for Week 1 through 4 weeks of
|
C
recovery, staring on Study Day (SD) 1. Body weights and physical examinations were also
recorded prior to SD 1andnotusedo reportedbecauseofadelay inthestart ofthestudy. Food
|
o
consumption was measured weekly for Week 1 through 4 weeks of recovery, starting on SD 1.
i
o Clin"icalChemis.tryand CompoundLevelAnalysi.s
Cc
`Samples were taken for clinical chemistry evaluation and compound level analysis from
|
all animals immediately prior to scheduled sacrifices. Blood was collected from thejugular vein
|
C
into a serum-separator tube. Serum enzyme levels of alanine aminotransferase (ALT), alkaline
|
`phosphatase, asparatate aminotransferase (AST), cholesterol and triglycerides were determined.
|
cM | 0 `Serumsamples for clinical chemistry were setonPAtIinChevyChase, MD for analysis. Serum
|
o
sample for compound level analysis are being stored in a freezer at approximately -80 C until
|
shipped to Dr. Kris J. Hansen, 3M E.T. & S., St. Paul, MN. The results will be reported
o
TR
|
oC
Interim sacrifices were conducted aftr 48 hours, 7 days, and 14 days of exposure to the
|
test diets, following blood collection. The animals scheduled for interim sacrifices were
|
C
anesthetized with CO,, weighed, and exsanguinated. The abdominal cavityofeach animal was
"
optehenliveerredmov,ed,weighedandliversamplescollected. Theanimalswerediscarded afer
C liver collection.
|
c
Terminal necropsies were conducted, following blood collection, on animals scheduled
i
for 1 and 4weekrecoveryafter 14daysofexposure10thetestdiets. Theanimalswere
|
c anesthetizedwithCO, weighed, exsanguinated,andnecropsied. Necropsiesinchudedexamination
Ofthe external features of the carcass, all external body orifices, andthecranial, thoracic, and
|
tL
abdominal cavities, organs and tissues. In addition, th liver was removed, weighed and liver
Cc
samples collected.
|
no
3M Corporate Toxicology
3
C
! 327
COcC oowommo00spomes Nemsww ||i
OrganWeights
!
0
"The liver was weighed for all surviving scheduled necropsy animals
|
o
|
o
Representative samplesofthe left lateral lobe of the liver and any microscopic lesions of
the liver were collected and preservedi formalin. After fixation, the samples were delivered to
|
CL
Dr. Sandra Eldridge at Pathology Associates Intemational, Frederick, MD. Proliferation cell
|
C nuclear antigen (PNCA) evaluation was performed on the samples. In addition, live sections
|
prepared fromthesame tissueblockwerestainedwithhematoxylinandeosinandexamined
|
Cc
microscopically. The results will be reported separately.
|
|
C `Pelimitovl-CoAOxidaseTissueCollection andAnalyses.
|
oc
A sample (approximately 500 mg)ofthe right lateral lobeofthe liver was also collected
|
from select animals and flash-frozen in liquid itrogen. The liver tissue was stored frozen at
i
Cc
approximately -80C until they were shipped on dry ice to Dr. Ron Markevitch, Covance
|
Laboratories, Madison, WI for palmitoyl-CoA Oxidase etivity. The liver samples analyzed
|
0 inclulldsteaddy animals,withtheexceofpthetWyi-14o,6n43animalsandthe 4-weekrecovery
|
C Group. The results will be repored separately.
|
|
C TissueCollection forElectronMicroscopicEvaluation
|
Sections of th lef lateral lobe of the lver from al animals were collected, minced to
|
approximately one millimeter cubes and placed in fixative spproprite for electron microscopy.
i
C The containers and fixative were provided by PAI, Frederick, MD. Samples were shipped to
|
Sharon Ambrose, Pathology Associates Intemational, Durham, NC. Electron microscopy was
|
Cc
`performed on one animal per treatment group exhibiting the highest cell proliferative response as
|
0 well as onecontrol animal atthediscretion ofthe Sponsor,fromonetimepointaswell as the4-
|
week recovery. Thus, EM will be performedonone animal from the control, N-EGFOSE (one
|
C dose only to be determined), PFOS, PFOSA, and the Wy-14,643 Subgroups at one of the time.
a} 3M Corporate Toxicology
In
|
----------e-- ee e --e --e -- 328
EE
--
cC N-E(FOSE, PFOS, PFOSA
TRC No. 1132-100
|
C points, as well as the 4-week recovery, for a otal of ten animals. The results will be reported
|
separately
|
RemainingLiver Tissue
0
The remaining liver issue was frozen and sored at approximately 80C at Pathology
|
|
a
Associates International, Frederick, MD in the long-term archive for possible future analysis.
|
C Histopathology
|
Livers from each animal that was examined for cell proliferation were stained with
C hematoxylin and eosin, and examined microscopically for histopathological changes. The results
|
C will be reported separately.
|
C RecordRetention All raw data, documentation, records, protocol, specimens, and final report generated as
| |
C a result of tis study will be archived in the storage facilities of PAI for a period of one year
|
0 following submissionofthe final report to the Sponsor. One yearafter submissionofth final
|
report, all of the aforementioned materials will be sent to the Sponsor and a return fee will be
|
[8] charged. All rawdatastoredonmagneticmediawill remain atPAL
!
:
c
|
|
t
|
0
|
-_
0
3M Corporate Toxicology
15
|
|
C
|
32
|
c | Cc
N-EtFOSE, PFOS, PFOSA
0
}
RESULTS
TRC No. 1132-100
|
BodyWeightsand BodyWeightGains
|
C
Mean body weights are summarizedinTable 1andpresented individually inAppendix
|
o
Table 1.
Appendix
Mean
1A.
body
weight
gains
are
summarized
in
Table
1A
and
presented
individually
in
|
C
Mean bodyweights and body`weight gains were comparable in all groups throughotuhte
study with the exceptionofthe 1-Week recovery animals on SD 15. There wasa 14, 8, and 12%
|
C
decrease in mean body weights in the 300 ppm N-E(FOSE, PFOSA, and Wy-14,643groups,
|
respectively. Mean body weight gains were decreased by 62, 32, 36, and 35 % in the 300 and
|
a
100 ppm N-E{FOSE, PFOSA, and Wy-14,643 groups, respectively on SD 8-15. In addition,
|
meanbody weightgainsweredecreased inthe 4-Weekrecovery animalsby 40%inthe300ppm
|
C
N-E(FOSE group on SD 8-15 and by 38% in the30ppmN-EtFOSEgroup on SD 22-29.
|
tL EeedConsumption
i
C
Mean feed consumption is summarized in Table 2 and presented individually in. Appendix
|
Table 2.
|
tL
Mean feed consumption was comparable in all groups with the exceptionofdecreases of
|
C
16% inthe 14-Day PFOSAgroup animalson SD 14and 20 %and 14 % in the 1-Weekrecovery
|
30 ppm N-EtFOSE and PFOSA groups, respectively on SD 15.
C | TestMaterial Consumption
|
CCcL AppendiMxeTaanblteest4.material consumption is summarized in Table 4andpresented individually in `
Test article consumption averaged 31.6 mg/kgfor300 ppm N-E(FOSE, 11.1 `mg/kg for
| i
Cc
100 ppm N-EtFOSE, 3.3 ppm for 30 ppm N-E(FOSE, 2.2 mg/kg for PFOS, 10.8 mg/kg for
|
o
PFOSA, and 10.9 mg/kg for Wy-14,643.
|
00 || C 3M Corporate Toxicology
16
--
|
330
|
o
|
C N-ECFOSE, POS,PROSA gig
TRC No. 1132-100
i
C
Clinical observations are summariniTazblee3d,andpresentedindividuallyin Appendix
|
GC Table 3.
|
Notreatmentrelated clinical observations were noted, however the following clinical
|
C Observationswereseen during SD 2-15iamost ofthe Groups: tinmess, abrasions, alopecia, rough
C haircoat, acrismoffaecets,aindodianrrh,ea. One 48-Hour PFOSAanimalhadparaphimosoins
|
:
SD3. One 1-Weekrecoverycontrolanimal wasmoribundkilled due to a dislocated nasalbone
C onsD21.
|
C `TerminalBodyWeightsandLiverWeights
|
C
`Terminalbodyweightsandabsoluteandrelative liverweightsaresummarizedinTable 5,
|
and presented individually in Appendix Table 5.
|
C
Terminalbodyweights ofthe48-hour, 7-day,and 14-daypostdosesacrificeand d-week
|
recoveryanimalswerecomparable othecontrols. Decreaseswereseen intheterminalbody
|
Cc
weights in the 300 ppm N-E(FOSE (14%), 100 ppm PFOSA (9%), and 100 ppm Wy-14,643
i
(15%) groupsofthe 1-Week recovery animals.
|
C
Forthe48-hourpost-doseanimals,absoluteliverweightswereincreased by 13%and27%
|
C inthe 100ppm N-EFOaSnEd 100ppm Wy-14,643 groups; respectively. Relalivterwieivghtes
i
were also increased by 22% in the 100 ppm Wy-14,643 group. The 100 ppm PFOSA and 100
Cc `ppmWy-14,643groupsofthe7-daypostdoseanimalshadabsolute liverweightincreasesof20%
|
and90%,respectively. Relativeliverweightsfortheseanimalswereincreasedin the300ppm
i
0 N-EWFOSE (20%), 100ppm PFOSA (16%), and 100 ppm Wy-14,643 (86%) groups. Increases
|
o wereseenintheabsolute iverweighisinthe300ppm N-EXFOSE (44%)and 100ppm Wy-14,643
|
(1045) groupsofthe 14-day postdosesacrifice animals. Relative liver weights were increased
i
o
12-49%inthe 30,100,and300 ppm N-BFOSEgroups,22%inthe 100ppm PFOSAgroupand
|
0
114% inthe 100ppm Wy-14,643group. Increoafs2e5%sand44%wereseeintheabsoluteand
|
relative iver weightsofthe 1-Weekrecoveryanimalsinthe300ppm N-EtFOSE group. Relative
|
C
liver weight increasesof23-25% were seen in the 100 ppm PFOSA and 100 ppm Wy-14,643
|
C
3MCorporateTosicology
7
|
C
_--
|
BN
33/
TT
C
0
N-E(FOSE, PFOS, PFOSA|
TRC No. 1132-100
C
groups. Forthe4-Weekrecoveryanimalsinthe300ppm N-EXFOSEgroup,increases wereseen
intheabsoluteandrelativeliverweightsof34%and29%,respectively. Relativeliver weights
|
G `wereincreasedinthe 100ppmPFOSAgroupby27%.
|
|
0 rosObsersions | 0
No treatment-related:gross findings were seen. The following incidental findings were
|
C1 `nmoottelde:dlainveernilanrtghede2sp0lepepnminPFthOeS1g0r0ouppp,manWdY-a1s4m,a6l4l3riggrhotutpesotfsa1n-wdefeokcurseoconvterhye alneiftmaclasu,daa
|
|
o
epididymisinthe 100 ppm Wy-14,643group ofthe 4-weekrecovery animals.
|
'
|
tC
i
: `
| |
c
C
|
:
|
|
c
C
|
0
|
CUm m 3MCorporate Toxicology 18 |||
G
|
--_--
-
332
0
0
N-E{FOSE, PFOS, PFOSA
o
SIGNATURE PAGE
TRC No. 1132-100
|
|
C
Study Director:
0
`Technical Writer:
o
WIJEL sthbo Fiotnog Qf ofco
Gary jolfe, Ph.L), D.A.B.T./Date
imberly A. Ldyton, B.S./Diie
|
c
|
o
Report Supervisor:
|
|
C` id wl | 0
Lori B. Kaiser,Espa
|
0
|
0
i
0
|
c
|
0
|
0
|
O
i
C
i
C
3M Corporate Toxicology
19
i
`
|
"333
|
D [rp
eo. 32100 |
soma or SnYeh1ans eres
Cc
0
mw TsGshe : ar Cell e PrE oBleifS eraE tionPStuedRy ewith aWB-wEFOa SE, PFOSS D , and PFB OE SA in RatE s QB
|
0
iwm w BmewomWta owwe m mwi emmtoH omma3% aoews3
C
mESTaVe; 1132-100.Sse:e.SEX: B88a WALE GROUP: 2 (7-Day Post Dose 8 Sacrifice) 0E 8 0&E 8 00a
i||
C
nwvea ooW29E.w2o W 2.4 oW26.8s 2W7.o1? 22o9.}9mo%2w.63 2o7.w3s
|
C ET aaw sSrhas E o(nf3TTREFo R EBs S Be & aa S &a o |!
C3 rs iwwow Wmmeti Ewye omBeR3 mOsWi mEe3 omme3 omms3
|
|
oO
w;sow. mBaano amndss woamse: 0m.7a9? 2m.3e1} fwoies3 modss3
Cc mEae TT oMsee: .S EoBBBSTER0e8gma 8@ 0a 9 0a9
|!
0
w wi w oemas B ms"4 OBom?
mWree2
mTe? emmea3
mes 3
i
o ore
mwwoOEmRaTEm%eR mWam3 Wmsm3 moam? aomme$ oaus3
| |
C 0
os
eo noBwarRY mWms oWme3 mWee7 mo2w? wWrse3 woews7
|||
I oT Te RE Pr
|
Gc
NOTE: Terminal body weights for all Groups were food-fasted weights and will be reported separately.
|
C SB @S& TiicL onhnroae0 rmm i Cc
7) = Uy-14,643 100 ppm
o 3 corporate Toxcotoay
|
sd
C
|
0 esos, ros, ros
nee, 131m |
C
soJns S-- E hs
|
r
ow
TSee e Cell S PrG H olifeS ratiE on Study G eewE ithrN-ELFtOSE,
PFOS,
and PFOSA in Rats
8em0s
&we
ooom
i
0
wW : o E me5 Tmr: wwsas mwe7 ommr1 moew3 moem? ||
C
ave
weoOwamRe
i
i}
W ma omms
3
:
oomme
7
moam
s
wwee
:
momee
:
|
|
ons
C
a ison %w32a.9 : 30S5.E9 7W32.e8 R3.E0} 7 33R.5g s 30O7.W1 ?o319w.1
I|
OB 0
wa
mi omOaER3 sOeRet mWee2 ommes wome: moomee2 osms?
0
a
w ; maOW3
ome s
omma7 omme1
oowmse7
wosw:
woem3
|
0 ore :
gOMmE3 mSey7 wmae3 owsmy7 uwse2 omme3 ea gs
i
C
FTF Tens than 05
Analysis of VarTance using DUNNETTS Procedure SS ----------
|
NOTE: Terminal body weights for all Groups were food-fasted weights and will be reported separately.
|
g
<B G@1) =rchonita eroel 0 pom
o
hosp
Il| |
FBIEAT
|||
C
|
0
3 Corporate Toxicology
21
i
|
|
)
S
--
-
C
M-Exrose, pros, PrOSA
TRE No. 1132-100
i
o
TTT
ctor taroemaSrry or eHotaKIiatecanBskccmprot nats GT (ow Fob Be
po
TEE
EEE
i
Cc
o
mowe
Gwe
BOB 6
wmwooswr sonao moaN moem
008
oonm
0 e wo0e&8nh omah oso
i
wo
3373 3
|||
a
mepean ToWeOE: .S EBTG 8E0{TR 8 8EE kaen0&0 x 0a
| |
C
w iooeeahtH wW s Mwe: wm e? omsm } oso$ wosw?
ons
O
nwiea oos2.8 ve3.s93 aCum2 aW s3 nS114 3E .92 o 4.0
i |
o T mepe EMeawwe S sT B sGE S8 ma T8 R weI rE gy m8o m0s&4 , 0 e w&r nww ao i||
n
woos Imo ow om om o&
C ow 1s ww : w onmeEI eEms omws3 daa3 omsme3 aoea3 wosmt
{||
c vz bey oSmoa5 msau eomne3 w5es mdGr3 awae1 obme3
| i
C
rm
on
;
moeRTsmoe moms?omeom7 mo1m3 om297 o0m7
|} |
Cc
C
our 36
mw i oomma7mmi omme3 m ma3 omme} mna7 omme$
i|i
RT mT
C tSe:eAnaoyn Lin eGroupBs, l16-Hur PSot Stos E ScriFiRce) aA nd 20Sa lPost Dn oss ae cc)eers ot reported oe to
||
CC @B S=cEIoErE0eRle.mE BIBrNImEREATn.a were om |
C
34 corporate Toxicology
2
|
0 wee vo
see
|
Cc Tn CoLL protfaraP cie SantdwithT M-ESrot, FProe--s _anP-- FOinnte8ats
0 pe SeeBH 80&4 808 4
G m ps beb e m 8 0 STV: TIE
SEX WALE_ GOW: 2 (7-Day Post DoreSacrTIce)
|
gT p seme in ox M T | 0
PeRICD. SUBGROUP:
in
2H EX
in
Su
oN
TH
bm4A | C
;sor wr7
3 pics2 5.753 mi}
er1 0.822
||
eT | C
so.
am
saz wr Seo 11.64
68
C
bose:
a@ &
@
@
0 we
0 own
m ts on rm nett mnrfS egem 1 gC
Note = Control feed given to all Groups during the recovery period (SD 21-80 42).
pimy mo, oC
BZ Wrs10 tpom
BHHEiLRbLS C
B256 0rm
I
C
3M Corporate Toxicology
23
|
GI
| 337
-_--
0 wars, ors, nom
nee, 132.00 |
C c
E poSmyee n Col rsf ttes"tisoTonmAaSyrTTB7eEwh3 tCCE oinEetiIWnwshro ay r6c i pe wo
i!
-- T mmee _ mwyr a wH a e Gwe m0r&4 x w0s&8 mieasw
0
i5.0. ous
% 19.09
:1.36
8553
6653
2.0s
5.7s 3 12.03
|I
0
im wmw o% mWeEs3 oWmw} wwme3 ommee1 wowes3 pomee2
i i
a oz W iWmsW 3 wr3 Wwse3 omme] oomme3 ommr3 oemeee3
| ||
O are im wm ow s3 wwiy7 omEe? m om3 omme7 mwrr7 ow3
|
C o
oars im womoos3 aSeE$ omweee3 omsw7 yommee5 omeme} oammee3
C1 on iz m i Rme5 wwem3 E we3 dwwe3 m we1 omes3 oemse3
O sRoto=LrTxEdceoIrmummpatroeAsnT Eorw6aRdtoeDconf 0Be4a2r.sywiparStOesR0TS2P11e0e0r,s
i ||
C GS B @ +Icoi nRtoE l 0m EpmE
C
B &(5) = I rPOES 2E 0 ppm.R
C
_
Ji
C
3 Corporate Toxicology
22
|
C
{
|
T33
|
o weose, ros, proms
nes
1 to. 152-100
C
Cott rotteeseoHayr oFwNiIhCAoLecescarTIosns rst te
|
o}
ma ppugm eosseee:weer iaw
a$ a fTES6 T,8 M Sw
e8w
o00w@
pAp--
||
0
[Noirma
TBsoorok
TB oower m 9TxETww er o rox
fosworex
5 :
ox
o1 rNTsee:ractoantreKsaL JoTehly
BT3 ooto TI
R oswuorcwomtekx i dm
Dw sowaemr w iuokrwJ8o'os
s3oo
||| |
o
RJacehnairesat
C
[Larcrtimhation
:: ;: : T:diwm oslu 8Se :fia: :Toxo: oo : Teo o
||
|
te
To 5 ` : o :
FT TIoseE: S WoOE G@T CayTETPtSa er
am
C 0
W mYew. oo aervsd wewow arimnation
fw fn Sn 1Tw ss oc Gs we
S5 eer
8 Ss um
e &5 n5000 w Lax Jum
| |
ws
o : 3 5 3 Tao
o
ThYeoe.rraotmbasruisLd
ith
SBwo aoo sddum TwotE
hZs omo Gd
lSs iwm iE
Sss wheo
SsSlooow :
us eew :
| !
o mMe To ETsa EmeRewS E dw G e Sx nfaya Fe p8s ey8n &Q 0O
|!!
C
NNoo.rmaabsarved
r0ox sSer s dex 5Swe S5 wor sGrom a5Jowm
|
C oNrYoeor.maolservad
Sort en
PTnoaom dssom 3sSwe sS: um S35 w sS: um sJ3 um
|||
C oaSrYToeor1rascrtoaulereKeHdL
T0oor ss we Ps im S5 oo 5 wor J5 um 5Jum
| !||
jj sSTfooftnt receesm
0i oSom0 som 0:diwEoo58sik wsTiwEix 5d3e%im 5o5em0000
|i
C:
@3@1) L=TCioneEtEtrtorloo0Sd1Hp0Eo0pmponmm
{i|
C @6 22Hhro0easntS0o8moTmE pee
{ ||
C -_
0
SH carporate Toxicotony
2
|
|
[se on rem
er. we
C
ET
cot protonsosmom[S A--Nr-- LTy, oy ae St ro rot ote
|
0 ome ER. BOR 80808 08 a
|
A3p--
wBoowsJu s JomsJum iJus 5Jue D3 ue
||
C
C
oa=N=ros. ,Cbserved
--,
PH0Bre oEwAJg5e om uA5Jm om dAJyom um lJ5e e ff5 agm D5feamm
|
o
aA-- DAY 15
C EEen
Bwuor sJum lyowsJu Jsum sfemslem
||
P HEOPEI T
EtL a im
C Ew=ratrond 0 J fs,
PBTwuEoEs sLoJEiolm JIsjoWmx Jdps e umm sJoiwiuwms m olJuwmm lriuawm S pode8gm1optm b moym
o O " TT mTR m RR eeB wm
Rp--fmmer 4 2b 36 ef Pe gb ju
|
0
ey
Bun Jom lew Jum wm fom Drm
|
o oaro28eoipynens
PJBPo earofbSeosm uasGf3ew um s Gf8e um sfiaammspSoes um f|8 ox
|
|
C i.
tml
rs
|
o [oJ Eyert
pPBtorwxoogJ5sussdd3em ex is l3m mwosJope e s lg1ehr emgl8 em
gp wPB f F orii em Em sms 8
tw
8
|
gp} BB L gimuIE EReEmE'
|
3M Corporate Toxicology
26
|
Cc
|
||
oo EE img fossil d C wera, pros, orosa
1 bo, 1132100
|
GC|
ov
oe
Sol proarasStouiwToHOwFEinGh3UMCeNoEneGtroisnCeu,eod)s10t3,ian Ey
pro
in
sats
EE
|
||
C We hNoE:ecroinerXvetd mew dw:Tee w fHo0 B.: 08o: e O0o:8 4o: 0o:9
C pwLaoezsaves
oC
Ih
B': em S:s ux :sdum d:s um L:s ex 5fiaxmgS5 oo
TNUooirmmseattetsnion
.TTaSo:
8:;
::o
s Tm
6::
3::
C opneo2r3oxarved
o!
bhten
[T:SE m fa
Gi0 um
Ss: om :
s2 dum.sLex i:
5:wm :
8Js e 8
|
Notmaation
. wos: :: o ToeTmo8 ::
||
C oarg 3asrte
o
oe
'PeexgsJum Ss: om dsiemmo ls es us: m 3sJue
||! i
EMeiedprhearcentaa
iTiEoo 8:: o.Si :| 8:: :::
||
C
{acFimation
0 onoTare3tammser1e0s
0 Tao imo
s[rIo Gwe s wm sSus sdum sdum d5 o
|
|
1
Reirttmien Aocia
aE TmmOoeE noo
sh 8:
F imWomEITaE
:em 0
iHiE w :
oO
SAerlwttn oo 0 Pr----
vo
om oo
5
BC Eros en
& INE wo
||
0 Bf5 rhEioEzeogmiia
|
BOE
C 0_co--rpor_ate--Tomxca--teay
27
|
C |||
0 ross oe ven
en vim
C a cu possotosn oEr 1L55 EAaeNEsScHoAoTr omy |
Cc
T me oBw BseoedeaE HHomsE momoOe0c 4mo&0s0e8 maaonswoa ee oopaoes
0D
v me TE-SRES.
Soh Eon GE Te eR B08 0&4 8
me aTEa
| 9g
wWw omee omms mr oscNsa Ea oma= omma
||
Cc
o
B me TT-GiwwSmwe. w0a 1e0T_P Tdm m8aeB5 w e Fo m0o iH5 r0s&r05 A aaaax35 0 e0w n45 ofoeo5
|
0
w7 oodswonB&H? oiH} m ma? owe}
||
o oAY 14 w iww oe m8Wms oWseoy osya| oaa? oaw} oome:
|!||
0 0]
mefp--msw TIERB-E--3B RtB a G x am 8 T w s 8 F x----d--8w w------w--8a--3----6 ----4w----o ----a-- w Boeuem moemMoomma osse we ms me
||
wen k
G4 e 2 oas m3 on}
;BodsS eoEmme
as ey
osse?
oaaei
saui omog?
|
Do i0-7_2--mcrmt e0m
|
c
F S3) i= Wa-nnECnFL OenSE s1,00 pom
OC
0) = Uy 14,643 100 ppm
C|
c [_-- p----
2
|
|
|
|
342
|
C
C vaso, ors, rom
ete, 132100
C
co rot arseotmieons Boutry aEewbh4 mEiniancmaoprici,onandoPmHS tn tts TO Ei 53 ok Tory yr er
||
C a r Saeem(ShgeSw f Te feeSf@
|i
xe
0 oar 1s
ewdmod0e.%0 B 2.7? oene3 3a.63 J2E.33 N 2.43 08ne3
|1!
C
wiowood0%0 aW1o? d0E23 3a.05 d2a0s W9.E83 010g.05
|
i
oC BBToTevtTree em
|
o fBB& iIAlESe.Te
0
||
C
!
r 0 Corporate Toicoteny
2
|
|
C
0.
N-EXFOSE, FOS, PROS
ET somEaL0SsuGEroeRsvTg rRoneniEeSsyAtceea 1 or eiennmics
18 Wo. 1132-100
|
|
0 S=Sehe vor gn
0 Eg8E xB8&E 0B8 Ba6088wOoqfa
C
i;=h
wFeOaMomEms oowmaOCE ovmCaR oommheE womrRg woew
C
ne pios Vso.
0u.6s3T4 ON0Eg.eR3m o03s8s5R3 R0a5m1o7 0ommeR 0ne%omem e0.s41s0ode
||
|
0 we cp=oV r wen ESETSEREsaw BseCwMMMEsEe eNaRmEEamoh esNioSw
|||
Lo U Se =m ee e 0SB0H a8mB e8e H8 4 m a w r 88 80o0m 0 |
0 or fiaoVono
waBOTooSmOaomoommeomy
moawome
oowwetey
ws hy
moemvy
0
er pnts iA)
SLIToToSsM SgEscE Essemag msmeemoconumam oedy
o ve c==g vem CSEwRBOaTWmTR CCsAaEe oNsiEm 2se%moby saeakg eusweolny
Cc
0
fS=ereea e
BBW OG&S Ba088T 8a 088 8a 00
|i|||
C
foF; d
wTaBEoonEmggo oowwesRE oowmeeRg hmoems woywhg mwomyma
J|
oc)
Ler @youswsnunes iso.
O SWOEuS 0naanmeey nlieassTeg omsoenose omsumem sivenay
|
|
0
po=v
C SEWE cCagm T oaNm ecWkaEm E sumoly w woiomn ocnuryaem
|
Cc m E m F TE EE RE EEm IANT E. a ||
- C
Subgroup & = N-EXFOSE
30
ppm
1
o
3 Corporate Texicology
30
|
|
|
|
o wrest, ors, oron
eo. 13200 |
o
Sao n of asor UTE LIVEy R LTEABTLTES Ce(CoyndtinAued)01S,RGaTt rsoyhae RATIOS
|||
C
RSoTixVa:n:TISET00 SON MALE SIIO8HEED& GROUP:4 (1-Week Recovery) 4wea 8we ow
1
0 [p--boeN
F msaewms moWe8 Eweomms cm meocmane
i
HE
ses : 3
|
C3 ver @ooaowwsaunes TnaEm CcHusSs tw DnsReONneEs MmeEn Nnnm
|!|
i
17
To
33
0
Liver ct=ig=o~r ram)
HsRaw
eOHmERTo
JaSm
SmEoTSTsEw
cNoExt
ew 3
|
C o
SasT obsi:r: ha E oR @ R8 8w E a 8@ 0@
||
son ra=Ar @
a}
i
Wwas3 wooWsnThBweROwWeHl 8m2s wWst owwr7
|||
o
Liver iaos (G)(ABSOLUTE)
smiamm3 cobumspTmVTikme mowuemsy neerr sLenae3 mnaem1
i
C 0
ver pei=sson satan Gsims3 eCalimmToosaRe oamae7 osmm eoslss osnadr3
i ||
giSEirm aer 1 +m 0 T om cce nn trl)
ErrEed aR.
a.
SSeienb7r=Wooy-1nu6,6pt43o1h00pen
1|
C
3M Corporate Toxicology
31
0
8
oanan
Leoann
!
Ohm le | | go.
-
iad
|
0
geziiz
agrees
ERENT
|
0 cama| gan |S
|
c
5
BEEREs
Of sma] gma | ER
|
O| =1gF ae e m | afn e | |
|
LEsgl gE2EEEE8EEE| gEfRiiEE
dors.
0 | py pa| ga | EH
*|
ol : 0
EHEE fcoRnemdmeadcsnaadneyn [|p cRfnioeese
33g]
55
| Vin Ban TO | 0
SEER aERREEain eRgResss
B0
cZEhAaRmEsAiRaAnRaNsS [B5 oRkemdid
:
Pm
Suan
o| mmm pl nie 4
H
Cc TCY issno Hip 34 ] HE 1D FEE
Hhiasas
|
2FAA
|
Fini]
Eb 3ckleadsaegs
[Rfdalsnests
To
t
FERERIEEE pgged i |
sah
og
04
: i | :0
eH
| !]
|
`
dE
i
|
`
Fig
;
|
o| ,4;
HBAiEd :sl:
Uli
Jp
on ;
|
:C| i |i Hagnun HHfoenime|:|:
||
i oo| & | pSaAg Terait |!
"|
o| ae||
jE
|
o| R8FE Lhg3iEsasEE cijagn i
||
c0
Pie i :. ] Ei :f Shamdaasaaasniess fa |, oh i5i
|||
cll hae
Eres
i
said
hon fi ite
P- o ||
C
:
i
BPep i s p -- aF d 2 BTS a |iHsiuaninal
Flinn
Ei an
P|
Po
ol siisen
:
|
|
0 | oY
03
|i
e
|i
c
|
C
[i --EE
HShioereis|| sSpaandues
!
C
5qd glaasesveesn
Rslhaennnsnde|| sRlpaanRasnde
o | FEE
| [gid EZEhmsEas
OC | 88y e+
sEhoLzzEe:
s383RE| zadadE
saleeardne| [sspldoagaasn
sRlEeLnaAsYa|| zelReEednd-s<
|
-
Gl Oi omy
o i aul,
JERAARR| RAE
| FDio | lw an
Iz
5
5
5
o| BEEEECETRTRE FSIS sbi lLSe
0
l zfsciz 33ad | EAHARS | HSdRYE [o HEvdsR|
5:
8 fS8l3o4o3a%aeBoRaAs||[ tgoannnaessd ||[8 dRae-dede |RB sEloaEee- [3
||
:i 3 ehhaniaEmisennenEaEy fGy ZRenoEne fo SEenRsorMy Hhaenneann [f2ab
c 2 6 SfmEaininRnAaRaEnEy |[ fSueTns|ff fclianvees|[ sohdoandceed E(BooEoilEag| B |
3 CEfEomeaEnEgeEnss E [8 loE ennn [8 fEssaEnege [E 8 fiE neen CL[jEoCEEIIRZEENS | i2
DC8l [liadnlsiaanssseesaeneers [f3rusiansssavnsn [f3uleseesaenees [l-diieasgnasnan [(2H1E1H1E1|| &
-_--
03
oy
#i
|
|
i
1
|
0
Fr
i
=
3
aCl ls Pre
jree n
i`
on
FERE EH
Fo m
2
i
| BY
Shnesn
i
C1 4 pun Fa : o| 5
bbs
:
BY | Jam i C
Sus Hc
E==Eas
2
o| Flin Hn ; Bed Sena i 0
ilps 25
eu
i
o| Ba... [EEG i
HE Imdddd
i
i"
:
of gmm FL EL [Gps ol f
ol | L[wm
gpm
ERemw
fam dg
q(msEElsa
g
feeszannies [Fass| BE fgets
C
c;
8 thunsasians
&.3 HISSSAS
B shansannene
E ipesiaiaing
BB chyna | SF
BE euas i
Hig
Toa
|
||
|
||
| -
|
|
|
||
1|
3i i|
FE
-
Oe
o:0;
:
o
GC
oc |
iq8of rIFm -
o | i4 i3
og I
o
o
|
|
5Be
SFhEaEm
co|| EWlihm
3SBuEs33iR|| HBEsREER
s[RSReORs| daa
Samar| ae
EaiaaEng|J
Lies
Hee
l|i n latitem
i
|
:
|
P|
|
::
|
i3
|
|
i:
i i
||
iH ii a|
it Bens Gon Gs 5 0 |D | co] Tk
]
|
:
co
E
sl...
Tessas
|
Gene
FI O
fi .
ih i
||
.
Lo Sean aa gees ol... fg Eliit
|
C
ol
aaa mul
Hezsananase fF
hand oe
SEenl n Foa ne
F
IkI:i
2 gh
fi
ji
dB Loren
ga | as Hy
|]
|||
iIa cd shrsnsessass
oa e linn
PE
in
ee
an
|
sil):
Ea
--3%5
--
!
-
oy
Cf | mmr |
|
C
Ffii aEgaEsg ffiessse oesnEE
||
;
i ses
c Rk ERRRRRNNEE PEE
Reged
|
NL WO
5
0EE fag, FIaaEs .
RSeas isppaassE
"|
o | d WjT e pe m]im | |2
||
:c| HTpo fn2 |SHi h$mn 4|2i3
|
c
a Pas
Ha
|
I c|g pg lisen53u4 f==E= HE rr rrere gifoe eiot
|
OF bimbo 1 1] i4 SoRnARRRIA pCsEEEsNIsEaR SdEaRnNn 1 212 |
mmm nn |;
-
-_
3
|
|
18
|
34i
|
|
;
pe
2
Sa
|
0
Ei
|
6
gan gE
i|
oo ||B.
geass
peers
FI
olEi5y
f=. n | 3ln
a|
oo | hEY GJ am | mi m
||
3%
| E53 | EE
|
O | 3 guage|| Simsz | spe
|
oO | B p Penn Cian
0 |B Lo | HE i ad
|
gf EEE ga Edda band
Po
Cy pfs fppeated sina sh
i
C8 oan asannanees obeuenn | HE Po
--
I
0g
0:
|
C0 .
||
C
nan
_--
o0
dEl &gpphEosoEess
o | of HEE
o |B
NY own
UO led mms
B33 5.
| gn | ey | | || GGnn RZpBaEnEnReSn|| Rllavsassoim
| has| sani
3
5
&
i;
ll
nt.Jon = tf
ln ERSARE EXEL. 3S5dE | Zeexscle pEddesl
0
EEEARE 289 EREREE [1 zddsdd FRAREEE
| se ge pn Tal lea
p 8 [spasm Sen | an fel eet
leEeee hl
8 W Coles nlos k dctl eecisl!H TE
meee
3
|
||
. ||
oo
|
|
|
|
|] |
HE
[1
1
|
C wessose, vos, pros
1bo. 1132-100
o, Aa 1RGaItemariConsEcu e poirU By oIvIDosU oS urytohpSeehr3aTiiotnss NL
SevaiTy Loc" rue coouaey
||
C e BOE eTerrminal Kil G wi R
C HO Toerrmimnal xitt. Ho perm
ownitors
||
o
Tkehrminate
owonsit
HO tom
|
o
oTernminal kilt
waord3y
| |
C
Hoss poanrt
Terainat Kitt
woriy
|
o RO iTdeerrhmmianlal kilt
oars
rowysi
|
!
0 HOT dSioorrmheces Torinat kite.
wworii1 wi
| i
o Hos pTearrmimnal itt
owurdvows
i ||
Cc OY dnoirnm tion Termin itt
wor owwwed3y EH
|!|
a}
HOBO dTooornsmaaln rut So SE Grote: TTR
Pert ereSeren
wariy3
| |||
C RiOR 4 cesToeonmunirtions
ET
Terminal Kitt
sai wees
|
C Ho Teorrsntat xitt
EH wouritou3r
i |
Cc
wos dTThoeirnrmminal
owonwit3
||
} wo dTToeorrmmioa 111
ooonrssd
| i
oC SpSEiabrrarramonp o$2T< seWesrvreoomss, 31e000 ppmm
|| !|
o I r roeodiceraih Toi e
|
o #G7 =riinme ebre
|
|
0
corporate Tontcoteny
"0
|
0 !i|
o
TTT cB ut praoe teocrotee rrcbiSnetLn eRE3 tSBiEneeI os a
ha + aris
on i roe stom
]
p ----ET-- osrmaerat--Kitt eS--ERS3 ------------
|
o
#10396 Njormael e
--_-- haan
WiDAY 1-DAY 3 ownitows
!| |!
|E-- fre
worions
0 on oTermomtm xine
oEwrHis
i
0 woe we
ou vows
!|
:
o
T or r+TtPTeTEenrmoSinnalsKiLL omre Tm o eowe arysSe s
Toma 0 wow ph e x
i wouirows
||
C oe eTromma xi
owuyyours
0 woo ertha x
owryvow 3
oo rermm x
ownivows
o [-- Homa xe
Jwi .
D or ortha a
owxiroars
|
C os EeJ rhst
wwwsii
0 [--ha oso hpoom
owuiroms owty
{|
0
Tem at
ni
0 pSemraaeicnl1E2 m0sommcoRnIsRims
|
C eSRolreI &in peaS k, 108 pTm R
|
7 eo
eereeee--------------cp------ee--te--rererreyme
0 0 corporate Toxtcatoay
4
|
-
0 J--
mse, vm
o
rT s Sar t (FI aortcepdsU3ATcEenn vy ts
||i
oo
ho+ ris To
om xt
in To mwwooeiTs
| |
0 wee HweS aie
wipos
|
o [ET ha ne
wouysows
|
wo afrmr
4oun yous
C wos iormh an
wourivanes
|
0 ewes lwmh xt
wouivous
0
mt Tot xt
EwoHsi
0 oo Treom tt
wwosii
|||
0 wt j tEo -- e
wwo4rii]s
!||
Oo oRoh+TaEstedmourrmimonsx
re LTo TThecwomaryosar 3
|
o
MoE errmn
wwyi
||
C [ER BParaoghitnosets
aowasi3
i|
0 os eiTnatt tt
wwriis
{
0]
mToratt tt
BowsHi
C [rR na an
woaysoars
o a ehrma au
Wouyroars
o Sr SMheaalen1ld2r0lkpmaEe comnrR.t?E
||
0 S e ShraEse iintom
ii
C 0 Corporate Totcaony
2
i
[oss oe
16s, 13-0
C
+TmTarioct ort erota T a rSyaiSS hleorny Toe So noEaehtssfd oro I cs
| |i
0 Mids oTistaoiosn tt seen IR wwSEii
|
o won mETitt tt
wwrtii
C wor tmerhm an
owuions
0 Bin +raTtefmrrmos
Sevmei 1r5 TTE cowennytarsowmse
| i
Cc
Ms Tostorarionna Kitt SOI
oINS3 S
C oom Toereminal Kitt
EwoirH ony roars
||
a me Th a
wy
|
R106 Nformeal in 0 J Yom xi
wiDAY 1-DAY 3 owxyrons
i
!|
0
se emt Tom tt
owwriis
C wr rHmT xi
owuyroars
0 [-- frp
Wi--.
R103 HT Normal xn
wyOAY 1-DAY 3
|i
0 moo dtorosalm gi C Saran 120m const
woaryour 3
| !
} C
SHFreeere llaiigEnniIaRRE
| |
Sraend lenSon em
{
|
L ee erre--------------
|||
C
corporate eseteny
-
C wesross, pros, prssh
eto, v32100
|
a orm I vie 3 nin
|
C
gp}
S eTTETRTeSE--eme aGol potifaraE tiron Sntudy withLW-EEehFOSeE,oHwPOeySs,SandeE OSA in Rats ------------
1
o Moz rmNTAolromopaelcmia xi
wooowasriwd
{
||
o0 vo wYn aesan
wwwryi
i
i|
i
Todi eit
wi
0} oT wroors +TtEoaTwremrmtear us r pe ies oe owowneyis T
i!|
[Tom m xi e 4 e
or ort
wr vows
|
0
rh a
We
o mos oTerrmomalm xt
wwourie1
|||
o wo ertha an
oErHvows
[Ee Hm xn
wJia--,
0 ww rseam xi
awarows
0 ost rt cn
wouivous
os erm
oa vows
| |
0
Yh an
wo f ert p
We owueyom
i
B woiss tNoermralm a
moary10 8
|
Cc se SJ vhered+ 4 kBe rios50e0p.om
SS e nedh S A em
0 weve mn
|
|
eee -------- ree ee --------
{|
|
C 0 carport Toten
"
=
-
|
[ves ve ron
a
||
C A TEE Sl rrTJ ea II --e S -- e ee
|||
C
ANIMAL #
Togs
an OBSERVATIONS Wornal
SEVERITY
LOC
TIME
wi OCCURRED
DAY TORT
8.
|
|
C aEn
pwe e
o wo iBt
wwwiee
|
R10459 Eh Normal
weDAY 1-DAY 8
I
C
0
ows
ee
worm
TmEEes
aru rreSe T
wmoayovpgans
|i1
fe m[si
ewe r
C or pEome
rwpi
|
o ws mHoth au
owuafive
||
a ooEh
wdipe
0 l ows ermu th LL ude Woryvows
||
ie
ee
0
Tw xn
we
afe
wa e
|
0 ows hormat n
monysroars
||
0 ee eThma au
iwirows
|
o or h pomn
ofi i
0 E sSHnrzlenE libemR meeE,
|
0 fE eoe S reerRe
|
go --me--m ----------is--------------
||
|
0 wom ee oon
m2 se, v0
cg
o
T hm a+ m armase Coll pre oliferaT tioop nAPsPtundEy NDIXwS JiTm tAhBaELAE-RE3XE TTOh(S SCeEoe ,nctiePnR HEunOeSt,d)syas nd L pe rOSA i-- e n Rats Se
|
||
[Ep 0 vo mrtm xi
we ownyvows
on eYmth a
owaeroars
i
C ore oHrmht x
BonyEtour 8
C TE ae RIGS. rTNrormhale tu eT s se er coh wyaE DAY 1-0AY 8
|||
0C e a TjorNmormal. e owwieeoonAYe8 |||
C R[IETRE Nhormaal ant
waDAY 1-DAY 8 or vows
||
|
o orm fTerrmienatl Kitt
oouyarows sr mT
{
0 ESeolslabo[swtrariiEonep sa hay tieasWrLe oEWerRsE
|
o [---- rm a o} res eTomma xi
wonevows oWravows
|i
0 vo efrtn
owryyours
emmt u
oWuirows
|
C saharreean 21 r=C0Bomrs(,ContR3r0o0lE)pom
!|
|
o
See r arla e =E noEvrosE, 30hepom
||
C 7sh
||
|
C
i
Toe ------------------------
i
Corporate Toxicology.
46
i
-
0 om moms | C
al rit(oracSiSiAH3 SoSEnsnrnt,y 1
Oo m prate en pmmie-- a 1-- coEmeR--s --eeme
C
Etolmyen
wwii
TE
eo
0 wes wm
on ow1e
0
fe
oi
wo Th an
rwiar
|
C on eTrhsta au
ooa iron 1s
|
0 eee eEmh
oonu vow1s
pom
ov pe
|
Cc
wpTTermhinal
Kill
a
ooouAYiv15ows
|
|
0 we I Eehw
ownuyyvows
|
oc
0
fm fErsTpO[-- r= GOa T CISmFtrSSe ern seenoiwT e
wr yTo h
oonn vo1w
0 wes tem
on vow
0
pfomr.
0
E pom n
0} SEi rmeilm1i2r0tpI mmenmonEt)E
0 e A MEmn ihIed NEE.
owryowe oqys
Cc s------------------eereeeeeeeeieeen
|
0
3M Corporate Toxicology
47
|
EE
0 ems en
Fp
|
C S TT catrootteoaecA hFFhnayEesiA re etSpSE --h pr I cs
|
C H+ e taTienmsxt
ro 12 cnnwonyistS
0 wer mrtn in
oonu vow 15
0 os rroma
owuirow 5
|
[ER Hn an
owuyrow 5
|
C o
E --T-- Eonar u R p rm eT cwJ ouynt T
i|
et STeem an
I wo
o a Th x
wJyar
|
C oo tomna
woyyoe 15
{
a oo emtha xn
oouyyo 15
!
0 ET oorTrEamermwthe E m pepe Te cooorynyso 1T 5
e Eh a T on
a woz rormmta xn
ooa n ow 5
|
0 os ETfeSmortmext
WWwiEEye
|
o wos h ormt a
ooaw ow 13
|i
oO
#10515 mh Normal au
o fF ore)p bm--n,
wy DAY 1-DAY 15.
ii ii
c e SSShhhrreuadne eslbiuieieiEWBorem
i |i
C
[ji
C
|
|
C i ------------eeeeeaeseereee
|
0
3M Corporate Toxicology
48
|
co
w-eerose, pros, prosh
TRE No. 1132-100
LJ T Hive, Ses
|
C frSeTA. Cell proli(feCrahtiaTonpStmtudy saewitshLroN-EeCiFOeSeE,ccPoFOnSt,StsomndaPFOSA in Rats
|
C
wTeotm
wwsww
!|
0 or L hdaert e
wworiirows
|
o wots eTorotth
Wouiron 1s
wo e[rrtoc yen
wouivow 15
C
o
wos TEeTiritmi si
fra
re TT RT i ay ivm sor eT Toth Lo 102 coonsts
|
i||
0
ma W[ ormet .
[---- ou
Twhn TON TS
woriawe
|
||
o om Rero ou
wouitow 1s
o oa Terth kin
wouirow 1s
||
0
f om r rrreTra osmti ou
rrrTot
oohn ivow 15 Loc "Toe cia
Soe
|
i||
o Hate Tom au
wa
wor Tdaortm iu
Worisow 2
||
O wos dTorsma ou
oWwiow 2
i|
0] om fioTorrtna ea
wWouiEvow 1s
||
C wo [errompe
WoEo 2
C won am ou
WoaErow
[-- Terminal kit
WEvow 22
C om Teotma sit
WorEsow
G wos pHeorta ei
oWuErow 22
C} EoEsEsLTL heYS romemD cWaou wm EST Eaag:T ro amWdouysS ow 2 TW or C MINE RE WRIA
||
|
0
3 Corporate Toxicology.
49
0 ese
158, 200
|
C
TT ct poa tteorrTonceitaSe,3L(ScmtoiHa nsSsdprec Iancteer
| i
C] Ms mes+ soaiFpianria ts o Cn 1cs `oR awweeis in
Tom itt
wi
C
o
oor hTreormeaml xi
wwowariiavows
|
on rthm
oO
Terminal Kitt
wowyton 15
NE
|||
0
eETmnotm au
wWJnE--
||
ROO rNormaml x
oa 5oN 22
||
C
o
RfSTOrOVs: 1132-- -10mTs0teaotionm x"GiROUP? (1-Weeok Rneciovery)u1eITTanGoRoewoe:w3ey
|||Y
R10562 Tom Normal win
0 oss orm
WH DAY 1-DAY 22 owarirow 15
3i |i
[LL--
WE
|
o os ertna xn
owayrow 2
||
o
R10545 E-- TNrormahl x
TE BRbDwAeYy1y-DAY 22.
||1
]7
RoE NTormanl an
=
WE ORY 1-041 22 ----
||
0
R10547 Nformral.o
[-- Hm xn
wy DAY 1-0AY 22 WonEvow 2
1! |
Cc oso oHrtm a
ownb sour 2
||
[PE -- C
#10550
Normal
3
Terminal Kill
DAY 1-DAY 22 DAY 22
||
|
a} SeFerioeibn5a=nrWE -TeoHOSuEn,R 1t00spom G ran
|
|]
HT IR
C
|
o | Corporate Toxicology
50
|
|
WE soma | oC
ETE a rstson I eJn--e--rEeBemderPEo Ietes
||}
| Tn Medetome eyo a eaten
C
tpKheerimmatioxn t
wownzmz
C oz i orm --
WonEvow 2
0 es jeme
woryow 2
1
0 oe rm xs
J wy
em xi
owryiow z
|
a1 o
SBTOTeT T1 EmTaotoRmna xGiROUP: 4 T Ir WE (1-Week Recovery) "SUBGROUP: 6
or moeten
wWWwhyew
C
Termine Kitt
0
eumtc -
WE
soy o5w 2
;
,
#10859. ma Normal xis
WE DAY 1-DAY 22
0 wi ow TEsromh a mene 1c SoRowRkvyeso z
Sais t[mi=oan x sol ue "NNTeicEowa
o oz YrTosmwt cit
owwnyyztour 15
0 wos em
rons
|
LL
nz
|
Oo Roses Tdorosalm cit
oWnyEtour 22
|
o} or om
woryvow 2
|
0 SE [ HrEpR E E120IpR R InEcnNE tE?
| |
0 rforeesssinitonAm,
||
|
pSipb7g=rWya-16u,64n3, 100 pre
|i
Cc
WT = Ventral side of Neck
i
ge --
51
|
i: oi 0
MeEviose, bros, pros
TRC No, 1132-100
C
oa o Sen SE FFR ETTA SGeallrp]ral eC ratSiooSy ntnundy with_icke-EwSTFOoeSeE,odPtOSpo,aandFFOSA in Rats
Op 2 ReeTeam rxt e--------mmwaeteemer.
|
o wo Mapoeieti Ton a
woono oWareos n w we
||
C0 woe oTomme xt
woresows
||
G}
R10569 jp Normal
o OT rEeimht
wy DAY 1-DAY 43. war W3oshoa
||
Tom xe
wa
Ros i wo et
Eh ot sows
| |
Cc
pReTeddoenmed cit
6 wwDAYaa36
0 won EeTemntn x
nowraA sow 2
||
C
ri0s7% Horanl x
DWAYE1-DAY 43
Oo e R055 ETtEuNhornmaeleaa cwmniee e"ToeeSDneAYmyi1-sDAY 43.
|
|
jul
Terminal Kill
0 wom eHmitte xin
ES
rwyons
|
|i
10578 Tn Normal x
we DAY 1-DAY 43.
C
HOSTS dTeorrasianlat itt
. we emt
aoharr 15oaY 43
wn ors
|
Cc
a
-- SSseavwsennsm 12LN0Taeo orEmlminaacloEnnx0ttrRo
g id
|
OoLESR fEhrri i iineasr. EetRe
|||
Co
Bxm CRC= vai eeci sm ic of
ck re
es
5 Gime
:
|
_--_--
|
0
3M Corporate Toxicology
52
a
|
-
|
C
g N-EXFOSE, PROS, PROSA e i reo mviee3 cCaoilnnnee e TRC No. 1132-100
||
8
p o Trr TEeTrsh aCote pot C featicnt ey w withuleEbeSoTRoeiEow mtpeeseaa nd rE ain atntse r
o os mrta in
wfyypos
os rrmm xt
TC wom wm
nyrows
wr or
|||
Cees ww
ou rows
Si+rtEeTenrnionanl Kill
mene oc TDE AY 4e3s
|
c
-- b
Vorsal
we BAY 1-07
wa Sg | Oo
R10587 TNeorrmmianlal xitt
we DAY 1-DAY 43
i|
a
oa orrt in
wOwNsoSawn43
!|
I}
T-- eio em
a
La.
Nwownziraowss ne
||
00 fNroeraimton
a
ftrriiteonn,
7 a 2ou3Bvooww2s 5owe]
|||
{
0 Se n+TtTfEeenihognhmees Ges TewTeEn oeR Tii ceemLe T
o
pTym xt
FWEoi
|
R10592 Ea Normal x
wi DAY 1-DAY 43
C
C
0 fpneerrmtailmeieorn
gwo5 oW omwyarstoE w 8
i||
Reni
c
Hm
ni Wa ne
|
wo Toromm x
ownarow 63
||
C nom emt
on roars
|
C
dBEyEre iE TTlNolHramoamX lmExin
RdenETTHR l
W WE S BAY 22-0AY 43. Re.
TTR
or
|
|
o
eerste 1R7T == LReifgthtEyEey,e, `LReifgthtFroFnrtontLegLeg
|1
o 0 Corporate Totcotony
53
|
r-- r ------------------------------|
oo AE Hien ||
0 evs vo vow
1 to v2
C
TET S a aT JI I--MB S-- ha,n wept 5t0ee
|
ean
EIT rie
rh
wi
C [--t----E ee n
fmB wyyg n
||
0 wom Eh eu
wim -
|
C
phe au
I wyS
wpee
oouy
gc
SfTiUYe:T13E2-7S0s0ms en ET "GROUP? 5 (4eek Recovery) STwEO:ooeoi7
--
|
o
FSryl
WByma
ao wpYona itt
wfyrp
o - Ponh ct
wrwiaie
|||
0 J|[LEN
nw-- aa
|
o
Een
oy
op tmE SreEEeE E)heimLE lamoEnRRyEE
:W)
op ESEaEie ReInEy .
Wem
0
||
C ||
o
M Corporate Taxicotosy
54
|
!
0g
|
spaazz
pass
Nl
Thesae
uj
03
ghaans
|
g
: il pasa: Shaan
Hamza
|
0| g3ig geass
-
eam
o| PiaE n aHImE
aes
pass
a|
o|
i
Hl
i
shan
o | plies da %lsszzassase
c Cdg Easasan33a3s3 |pp fSpeaasseaasnsnansasd p fIhaIssaInaaBns
Flames [lnm 6
stg f
BG faisgnygalhls||
Sis
--_--
329
ol
a4
c
Fo|o||
|||
: ] | 0
3
Ape
|
od
pn
|
o| i
3
i
shosaz
|
0| 3
I
0 | &ZH3;;
-irik
|
ol ib fae
|
Blk.
i
0 Pf thane
|
me fam Plan | EB Bodosssassss b ohesa:|BESE : | C
Faamazz 3zzsas
Hezzaz
.
}4
8 zzz |B 5333333333 | gosad Hi
i
]
Cg |e shenaz |p geasssssass [2R008| oiintd
:|
GC
|
pres
i
|
Cg
0 onan
ol | I
|
CJ
co| ||
||
o| of ses
|
B 4 is
|
0 | h42ed jZae=azzns
Dg
|
|
o |i EE "| 0 i peed |
o| 3 8d
a Hiam | || sa
lL EEE
|
Ol
C
Fm edie
Pha aiiy
s
o : oi kTpsssssasas i gana|a eSages i
-- c |
01
|
C|
gFlE=2I3| 82ERIE EEE
|
0`
d8 au E fiEsRIgEam 4;IREIREHERR:E
||
of 4%] s| 833 qm3 ]8 pi3n) pin] gn
||
C| | gi g sz sfpaes]) dgaen din] yes
|
SE RE ols dass
ud g
>S
Hgsa8s%AR3 R3IE:
|
o |dgeBteomr]e gigsn) yegn) qin) d1 :s | |
c BEpeupgenpisgginggin i
cB)ii hsEpb usflisiiattinrduldtiina
c
-
HERE
Cc| | gpl iganellday: n] gen af fig i Cf: [c risufeb in adannfgemfIaeM niE in |r |
of [Hinks AEE fi |
cl i a hlstR h ahb HE |
332
Cg
C4
ls:
I HEIR E ii
|
:
EEE
o
g 388
Hazer l 9s e
i)
.
ihEEE ER #832
Cc
FE
Cc Hoyas
Cl+ 5a fg el s
0 ER
1
;
EEH RIEE ANE
|
gI 93isdi "hi |
|
oo | f3y gE RHdi 34%] 438 |
|
old
hie
o: Giaimphlpain I .
|
1 Pf
ga i | Epis
|
Jiafiintdial C
FEET fFf EELiREEELrSik2
i
|
a. C
JJeze
Sq
desl gs
i
EE
i f oH
HE
#lyam
||
C|ygi F1 fgge:3i8nEfH yirnffdi. nSh fBHdin Enfge|e n g.l:
ctgf
3 i iH
in :
iiiHp5
4 5oEal me
2
RR HIER
HEHdaH #nE 1;|
S ~ 3i 33 dass | |
|
C4
oC
159) ges gin] gan) gan
|
o
|
C
IGE HAE RAE HEM Hi
oz B8 lags3i3]3 ga2s8)k ggl a5d3)% 3g=e3% 3g:e 38
i|
H leeEETT FEN W EEATFEATSFTE
||
C
ludi
HE
113 ; :
38d
i
3
o |i
EER EER EER EER EER EE
|
SlEl REE Eh Cc Wi lanfdennninil inhNyinld
| Mginblinpgiuptinfdin| | |
ol Feemfienlfdinliinfin fi |
Cf Hfgim:flinfinf5riniHgin sghily
Cd fle fle fle le. |e . |
C1ig G: 5583TBrle5ds5p ddLEs [fe EgR2EWB[EREE gESELEBSREE2sglR| BEBE |
:
i
|
-
E32
dist) gael gi
|
C4
|
. INEIEIREEIR EERE
Hi8E) Yi) Ba) gaan gan
g
|
oc | od EERIE EER EEIRERR ER
if
;
|
o. 5Ha-e PoeEM dAaEsE ldHsAeEs i2n
!
its
i
Ely ga
o | 58
if
:
EER:
5
ETI ITI | 0 HER fim gam gs fe
25
! HNeEdsEmL baEsEnkLdinERLE kdE snAPAE ERE IIARSS
|
o0f aE sulT deR nlE isuldT inlT aeR n|n| |
:
i
i
i
&
FE]
0
EER FRAN FRAN FRAN E- !
.i
i
i
i
i
ih
4 g
GgGcEeTsfiyHoEsS s f HAi R rge aay | F] F a8 i 88g E5
Ua elels fe ]s sl |e | HEE
23
i. g
FSeEEeLg
ihe | se
iCYHfEaSieiBeidgli88todoSle feAPidEedl
s gadiEiJPEdRygBYaeoisRa|dpErEeRd E)2
335
:Cg
8 |3 8
|
Ci gam) gis i%]
#
J"
C`
EfEiEl gFiRnSal HEeE3
oleJREEEEIRJEiR 8:8
C.| LIfErRe LgEEs: g| is
C all
i
28
!
;o 3B33yf es s EEaIR EE
EYE EEEL i
c0 Sla.nfit liG nE e ii
`
BIELREE Hel
Ciol[driesffeinJ iin i Ba
fCl F hRisHRk Eie EbaHi
|
|||
|
|
||
|
||
|
|
||
]P|
oo